Companies / Alignment Healthcare, Inc.
Alignment Healthcare, Inc.
Nasdaq: ALHCCIK 1832466ORANGE, CA
Financials · FY2025
Ownership
207.4M shares outstanding · as of Jul 27, 2026
Ownership
| Insiders | 4.13% | 8,561,257 |
| 10%+ / strategic | 14.60% | 30,284,884 |
| Institutions | 85.08% | 176,479,557 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 17
View all →| Insider | % of shares | Shares |
|---|---|---|
Kao John ECEOChief Executive Officer · Director | 1.53% | 3,171,634 |
Konowiecki Joseph SEVP, Corporate Affairs · Director | 0.54% | 1,128,816 |
Maroney Dawn ChristinePresident | 0.51% | 1,058,813 |
Scavo Robert L.Chief Information Officer | 0.24% | 487,685 |
McClellan Mark B.Director | 0.18% | 370,531 |
Kim HyongChief Medical Officer | 0.18% | 367,701 |
Joyce Christopher JChief Legal and Admin. Officer | 0.15% | 305,451 |
Kosecoff Jacqueline BDirector | 0.15% | 303,963 |
Burzacchi SebastianCOO - Mgmt Services Org | 0.12% | 258,630 |
Head James MChief Financial Officer | 0.09% | 184,595 |
Institutional holders 281
View all →| Holder | Value | % of shares |
|---|---|---|
| $460.56M | 9.32% | |
| $305.98M | 7.47% | |
| $289.45M | 7.07% | |
| $277.90M | 6.78% | |
| $260.06M | 6.35% | |
| $173.75M | 3.52% | |
| $122.50M | 2.99% | |
| $121.93M | 2.98% | |
| $91.55M | 0.33% | |
| $85.73M | 2.09% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Maroney Dawn Christine Executive | Sell | Common Stock | $4.87M | -228K -17.75% | 1,057,015 0.51% of shares | medium |
| May 11, 2026 | Kao John E CEO | Sell | Common Stock | $4.73M | -281K -15.55% | 1,525,748 0.74% of shares | medium |
| Jun 10, 2026 | Kao John E CEO | Sell | Common Stock | $4.59M | -223K -13.86% | 1,386,766 0.67% of shares | medium |
| Apr 10, 2026 | Kao John E CEO | Sell | Common Stock | $4.16M | -202K -9.59% | 1,902,741 0.92% of shares | medium |
| Jan 12, 2026 | Kao John E CEO | Sell | Common Stock | $3.74M | -177K -5.88% | 2,835,368 1.37% of shares | medium |
| Feb 10, 2026 | Kao John E CEO | Sell | Common Stock | $3.69M | -180K -6.35% | 2,652,641 1.28% of shares | medium |
| Mar 10, 2026 | Kao John E CEO | Sell | Common Stock | $3.27M | -180K -6.79% | 2,472,641 1.19% of shares | medium |
| Apr 7, 2026 | Kao John E CEO | Sell | Common Stock | $2.73M | -132K -5.62% | 2,222,400 1.07% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| General Atlantic, L.P. | Passive13G/A | — |
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G/A | — |
| Fmr LLC | Passive13G | — |
| General Atlantic, L.P. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ALHC | — | 01625V104 |